- Home
- MREO vs RERE Comparison
MREO vs RERE Comparison
Compare MREO & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- RERE
- Stock Information
- Founded
- MREO 2015
- RERE 2011
- Country
- MREO United Kingdom
- RERE China
- Employees
- MREO N/A
- RERE N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- RERE Other Specialty Stores
- Sector
- MREO Health Care
- RERE Consumer Discretionary
- Exchange
- MREO Nasdaq
- RERE Nasdaq
- Market Cap
- MREO 424.5M
- RERE 444.1M
- IPO Year
- MREO N/A
- RERE 2021
- Fundamental
- Price
- MREO $2.85
- RERE $2.90
- Analyst Decision
- MREO Strong Buy
- RERE
- Analyst Count
- MREO 7
- RERE 0
- Target Price
- MREO $7.71
- RERE N/A
- AVG Volume (30 Days)
- MREO 1.2M
- RERE 759.2K
- Earning Date
- MREO 08-12-2025
- RERE 08-19-2025
- Dividend Yield
- MREO N/A
- RERE N/A
- EPS Growth
- MREO N/A
- RERE N/A
- EPS
- MREO N/A
- RERE 0.07
- Revenue
- MREO N/A
- RERE $2,388,301,386.00
- Revenue This Year
- MREO N/A
- RERE $27.37
- Revenue Next Year
- MREO $54.07
- RERE $24.06
- P/E Ratio
- MREO N/A
- RERE $40.03
- Revenue Growth
- MREO N/A
- RERE 26.09
- 52 Week Low
- MREO $1.58
- RERE $2.00
- 52 Week High
- MREO $5.02
- RERE $3.70
- Technical
- Relative Strength Index (RSI)
- MREO 64.74
- RERE 63.02
- Support Level
- MREO $2.61
- RERE $2.64
- Resistance Level
- MREO $2.85
- RERE $2.89
- Average True Range (ATR)
- MREO 0.17
- RERE 0.14
- MACD
- MREO 0.03
- RERE 0.03
- Stochastic Oscillator
- MREO 88.83
- RERE 73.13
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.